Wed, September 4, 2019
Tue, September 3, 2019
Fri, August 30, 2019
Thu, August 29, 2019
Wed, August 28, 2019
Tue, August 27, 2019
Mon, August 26, 2019
Fri, August 23, 2019
Thu, August 22, 2019
Wed, August 21, 2019
Tue, August 20, 2019
Mon, August 19, 2019
Fri, August 16, 2019
Thu, August 15, 2019
Wed, August 14, 2019
Tue, August 13, 2019
Mon, August 12, 2019
Fri, August 9, 2019
Thu, August 8, 2019

Brian Skorney Maintained (SRPT) at Buy with Decreased Target to $181 on, Aug 20th, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-181-on-aug-20th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Brian Skorney of Baird, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Decreased Target from $202 to $181 on, Aug 20th, 2019.

Brian has made no other calls on SRPT in the last 4 months.



There are 3 other peers that have a rating on SRPT. Out of the 3 peers that are also analyzing SRPT, 0 agree with Brian's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Brian


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $220 on, Tuesday, July 9th, 2019
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $220 on, Monday, July 1st, 2019
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Decreased Target to $190 on, Thursday, May 16th, 2019

Publication Contributing Sources